...
首页> 外文期刊>Medical hypotheses >Exercise induced von Willebrand Factor release -- new model for routine endothelial testing.
【24h】

Exercise induced von Willebrand Factor release -- new model for routine endothelial testing.

机译:运动诱导的von Willebrand因子释放-常规内皮测试的新模型。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Endothelial dysfunction (ED) is actively involved in the mechanism of occurrence, development and progression of all the degrees of atherosclerosis. The established impact of ED on the progress and outcome of cardiovascular diseases, together with convincing indications of a possible successful therapeutic modification, necessitate the changeover of ED assessment from experimental to a routine practice. As there is no appropriate method for a clinical practice, scientists anticipate significant research efforts in the further development. Among numerous methods already available, von Willebrand Factor (vWF) stands out significantly. In accordance with the accepted leading diagnostic role of vWF baseline levels in the group of peripheral endothelial markers, and earlier scientific observations on the absence of its expected reactivation during physical exercise, we hypothesised this promising theory. We believe that a constant stronger release of vWF in endothelial cell injury leads to the exhaustion ofits stores in Weibel-Palade bodies with the consequent absence of the expected rise of concentration during the exercise. Therefore, we hypothesised that ED could be exhaustible vWF endothelopathy and the exercise induced release of vWF a new, simple, safe and reliable test for the detection of ED and monitoring of the expected therapeutic effect. In order to have a final clinical usability of the proposed diagnostic model, it is necessary to test its reliability in different pathological and risk states, and establish susceptibility in therapeutic procedures. The correlation with invasive functional angiographic tests and the flow mediated dilatation test of peripheral arteries also needs to be validated. We expect the proposed test of vWF inducibility to find its place in clinical practice, i.e. in prevention, prediction and therapy of cardiovascular diseases.
机译:内皮功能障碍(ED)积极参与所有程度的动脉粥样硬化的发生,发展和进程。 ED对心血管疾病的进展和结果的既定影响,以及令人信服的可能成功进行治疗修饰的迹象,都需要将ED评估从实验转换为常规实践。由于没有适合临床实践的方法,因此科学家期望在进一步的开发中进行大量的研究。在已经可用的众多方法中,von Willebrand Factor(vWF)表现突出。根据vWF基线水平在外周内皮标记物组中公认的主要诊断作用,以及在体育锻炼过程中缺乏预期的再激活的早期科学观察,我们假设了这一有前途的理论。我们认为,血管内皮细胞损伤中vWF持续不断的强释放会导致其在Weibel-Palade体内的存储耗尽,从而导致运动过程中浓度没有预期的上升。因此,我们假设ED可能是可耗尽的vWF内皮病,并且运动诱发的vWF释放是检测ED和监测预期治疗效果的一种新的,简单,安全和可靠的测试。为了使所提出的诊断模型具有最终的临床实用性,有必要在不同的病理和危险状态下测试其可靠性,并在治疗过程中建立易感性。与侵入性功能性血管造影检查和外周动脉血流介导的扩张检查的相关性也需要验证。我们希望提出的vWF可诱导性测试能够在临床实践中找到其位置,即在心血管疾病的预防,预测和治疗中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号